| Literature DB >> 32609628 |
Eszter Kotyuk1, Anna Magi1,2, Andrea Eisinger1,2, Orsolya Király1, Andrea Vereczkei3, Csaba Barta3, Mark D Griffiths4, Anna Székely1, Gyöngyi Kökönyei1,5,6, Judit Farkas1,7, Bernadette Kun1, Rajendra D Badgaiyan8, Róbert Urbán1, Kenneth Blum9, Zsolt Demetrovics1.
Abstract
BACKGROUND AND AIMS: Changes in the nomenclature of addictions suggest a significant shift in the conceptualization of addictions, where non-substance related behaviors can also be classified as addictions. A large amount of data provides empirical evidence that there are overlaps of different types of addictive behaviors in etiology, phenomenology, and in the underlying psychological and biological mechanisms. Our aim was to investigate the co-occurrences of a wide range of substance use and behavioral addictions.Entities:
Keywords: alcohol use; behavioral addictions; cannabis use; co-occurrences; eating disorder; epidemiology; exercise addiction; gambling; problematic gaming; problematic social networking; smoking; substance use; trichotillomania
Mesh:
Year: 2020 PMID: 32609628 PMCID: PMC8939407 DOI: 10.1556/2006.2020.00033
Source DB: PubMed Journal: J Behav Addict ISSN: 2062-5871 Impact factor: 6.756
Lifetime occurrence and co-occurrence of psychoactive substance use
| Cigarettes ( | Alcohol ( | Marijuana ( | Synthetic marijuana ( | Amphetamine ( | Cocaine ( | Heroin ( | LSD ( | |
| Cigarettes | 69.1% | 3.3 [2.4–4.6] | 12.6 [9.5–16.7] | 20.9 [7.7–56.7] | 13.3 [5.9–30.2] | 11.7 [2.8–48.1] | 9.1 [1.2–67.6] | 10.3 [2.5–42.5] |
| Alcohol |
| 94.9% | 19.7 [7.3–53.4] | 7.3 [1.0–52.9] | nc1 | 2.9 [0.4–21.0] | 1.1 [0.1–8.1] | 2.5 [0.3–18.3] |
| Marijuana |
|
| 33.0% | 18.5 [11.2–30.6] | 68.8 [30.4–156.0] | 114.8 [15.8–831.2] | 19.9 [4.6–85.7] | 99.2 [13.7–720.3] |
| Synthetic marijuana |
| 8.6% |
| 8.6% | 26.5 [15.7–44.8] | 20.3 [9.1–45.2] | 42.1 [11.6–152.5] | 48.1 [19.2–120.3] |
| Amphetamine |
| 5.8% |
|
| 5.8% | 214.1 [83.7–547.9] | 33.8 [13.3–85.8] | 87.8 [41.5–185.8] |
| Cocaine |
| 1.8% |
|
|
| 1.8% | 82.3 [33.1–205.1] | 52.9 [26.9–104.3] |
| Heroin | 0.7% | 0.7% |
|
|
|
| 0.7% | 91.8 [36.6–230.2] |
| LSD |
| 1.5% |
|
|
|
|
| 1.6% |
| Magic mushrooms | 1.6% | 1.7% |
|
|
|
|
|
|
| GHB | 1.4% | 1.5% |
|
|
|
|
|
|
| Mephedrone |
| 3.1% |
|
|
|
|
|
|
| Steroids |
| 2.4% |
|
|
|
|
|
|
| Alcohol with drugs |
| 6.3% |
|
|
|
|
|
|
| Sedatives |
| 7.6% |
|
|
|
|
|
|
| Other drugs | 1.9% | 2.1% |
|
|
|
|
|
|
| unknown type of druga |
| 1.8% |
| 0.4% |
|
|
|
|
Notes. Numbers of valid answers by each substance use are presented in the table header. Lifetime use of each substance is presented in the diagonal (% based on valid answers). Co-occurrences of specific substance uses are presented in the cells below the diagonal (% of overlap calculated by number of cases with both characteristics divided through all cases, based on the valid answers of the total sample) with the corresponding Phi coefficient. * Phi correlation is significant at the 0.05 level (2-tailed). ** Phi correlation is significant at the 0.001 level (2-tailed). Chi-square tests where the level of significance is smaller than the Bonferroni correction significance level for 130 analysis (P < 0.000394) are marked in bold. Odds Ratios and 95% confidence intervals are presented above the diagonal. Most missing data occurred by the ‘synthetic marijuana’ question (49.4%). In all other cases the rate of missing data was less than 15%.
nc1: non-calculable due to the zero frequency in one cell, only estimated with replacing missing cell with 1: OR = 9.8 [1.4–70.6].
nc2: non-calculable due to the zero frequency in one cell, only estimated with replacing missing cell with 1: OR = 2.7 [0.4–20.0].
nc3: non-calculable due to the zero frequency in one cell, only estimated with replacing missing cell with 1: OR = 5.1 [0.7–36.6].
aThe ‘unknown type of drug’ category represent participants' answers where they do not know what type of substance they used.
Lifetime occurrence and co-occurrence of psychoactive substance use
| Magic mushrooms ( | GHB ( | Mephedrone ( | Steroids ( | Alcohol with drugs ( | Sedatives ( | Other drugs ( | unknown type of drug ( | |
| Cigarettes | 5.3 [1.9–14.6] | 9.6 [2.3–39.7] | 20.3 [5.0–82.7] | 3.9 [1.9–8.2] | 5.2 [3.1–8.7] | 2.4 [1.7–3.4] | 2.8 [1.4–5.8] | 6.7 [2.1–21.7] |
| Alcohol | nc2 | 2.4 [0.3–17.5] | nc3 | 1.0 [0.4–2.7] | 5.3 [1.3–21.4] | 2.1 [0.9–4.8] | 1.1 [0.4–3.6] | 2.5 [0.3–18.4] |
| Marijuana | 105.9 [14.6–768.0] | 46.1 [11.2–190.9] | 31.7 [13.8–72.9] | 3.9 [2.4–6.2] | 6.6 [4.7–9.2] | 2.8 [2.1–3.7] | 9.5 [5.1–18.0] | 5.3 [2.8–10.1] |
| Synthetic marijuana | 21.1 [9.8–45.3] | 31.5 [9.9–100.3] | 40.7 [14.8–112.1] | 7.9 [3.8–16.2] | 6.5 [4.1–10.3] | 4.7 [3.0–7.3] | 10.2 [5.1–20.3] | 4.1 [1.6–10.7] |
| Amphetamine | 67.6 [34.5–132.3] | 70.4 [34.1–145.6] | 99.9 [58.5–170.7] | 8.4 [5.0–14.2] | 9.0 [6.2–13.0] | 5.3 [3.7–7.8] | 15.7 [9.2–26.8] | 13.1 [7.0–24.5] |
| Cocaine | 52.2 [26.9–101.4] | 44.4 [22.2–88.9] | 40.8 [22.5–74.1] | 15.5 [7.9–30.6] | 11.3 [6.4–20.2] | 8.1 [4.6–14.4] | 19.4 [9.2–40.7] | 14.6 [6.4–33.4] |
| Heroin | 39.3 [14.9–103.7] | 51.4 [20.0–131.8] | 22.1 [8.9–54.9] | 26.5 [10.6–66.0] | 26.4 [10.8–64.7] | 13.9 [5.9–33.2] | 51.2 [19.6–134.0] | 46.4 [16.8–128.2] |
| LSD | 126.4 [62.9–254.3] | 69.4 [34.3–140.2] | 46.0 [24.7–85.8] | 17.9 [9.0–35.6] | 21.4 [11.8–38.9] | 8.0 [4.4–14.6] | 56.4 [28.4–112.1] | 33.9 [15.8–72.8] |
| Magic mushrooms | 1.7% | 62.5 [31.2–125.0] | 41.7 [22.6–76.8] | 11.4 [5.5–23.8] | 12.6 [7.0–22.6] | 7.5 [4.1–13.6] | 35.7 [17.3–73.8] | 20.2 [9.0–45.6] |
| GHB |
| 1.5% | 61.4 [32.3–116.6] | 24.3 [12.4–47.7] | 9.0 [4.8–16.8] | 7.8 [4.2–14.5] | 32.7 [16.0–66.9] | 21.7 [9.6–49.2] |
| Mephedrone |
|
| 3.1% | 13.7 [7.7–24.2] | 8.1 [5.1–12.9] | 4.8 [3.0–7.9] | 22.9 [12.7–41.4] | 15.0 [7.4–30.5] |
| Steroids |
|
|
| 2.6% | 7.5 [4.5–12.5] | 4.1 [2.3–7.0] | 18.6 [10.0–34.5] | 18.6 [9.2–37.4] |
| Alcohol with drugs |
|
|
|
| 6.3% | 11.3 [8.1–15.8] | 9.1 [5.3–15.7] | 15.1 [8.2–27.7] |
| Sedatives |
|
|
|
|
| 7.7% | 3.8 [2.0–6.9] | 7.3 [3.9–13.7] |
| Other drugs |
|
|
|
|
|
| 2.2% | 26.2 [12.1–56.4] |
| unknown type of druga |
|
|
|
|
|
|
| 1.8% |
Notes. Numbers of valid answers by each substance use are presented in the table header. Lifetime use of each substance is presented in the diagonal (% based on valid answers). Co-occurrences of specific substance uses are presented in the cells below the diagonal (% of overlap calculated by number of cases with both characteristics divided through all cases, based on the valid answers of the total sample) with the corresponding Phi coefficient. * Phi correlation is significant at the 0.05 level (2-tailed). ** Phi correlation is significant at the 0.001 level (2-tailed). Chi-square tests where the level of significance is smaller than the Bonferroni correction significance level for 130 analysis (P < 0.000394) are marked in bold. Odds Ratios and 95% confidence intervals are presented above the diagonal. Most missing data occurred by the ‘synthetic marijuana’ question (49.4%). In all other cases the rate of missing data was less than 15%.
nc1: non-calculable due to the zero frequency in one cell, only estimated with replacing missing cell with 1: OR = 9.8 [1.4–70.6].
nc2: non-calculable due to the zero frequency in one cell, only estimated with replacing missing cell with 1: OR = 2.7 [0.4–20.0].
nc3: non-calculable due to the zero frequency in one cell, only estimated with replacing missing cell with 1: OR = 5.1 [0.7–36.6].
aThe ‘unknown type of drug’ category represent participants' answers where they do not know what type of substance they used.
Occurrence and co-occurrence of potential behavioral addictions defined by the cut-off thresholds of the appropriate scales
| Problematic Internet use | Problematic online gaming | Problematic use of social networking sites | Exercise addiction | Problematic gambling | Trichotillomania | Eating disorder | |
| Problematic Internet use | 13.3% ( | 13.7 [9.2–20.5] | 35.2 [17.0–73.0] | 1.4 [0.7–2.6] | 3.5 [1.9–6.3] | 2.5 [1.7–3.9] | 2.3 [1.8–2.9] |
| Problematic online gaming |
| 4.0% ( | 3.4 [1.4–8.4] | 2.9 [1.3–6.5] | 12.2 [6.4–23.2] | 3.1 [1.7–5.9] | 1.5 [1.0–2.3] |
| Problematic use of social networking sites |
| 0.4% | 3.2% ( | 4.8 [1.6–14.2] | 6.0 [1.7–21.2] | 3.7 [1.9–7.4] | 4.0 [2.3–6.8] |
| Exercise addiction | 0.4% | 0.2% |
| 2.3% ( | 8.9 [4.0–19.7] | 1.1 [0.3–3.5] | 2.1 [1.2–3.4] |
| Problematic gambling |
|
|
|
| 1.7% ( | 3.4 [1.4–8.2] | 1.2 [0.6–2.3] |
| Trichotillomania |
|
|
| 0.1% | 0.4% | 4.0% ( | 1.9 [1.2–2.8] |
| Eating disorder |
| 1.1% |
| 0.8% | 1.1% |
| 19.6% ( |
Notes. Occurrences of potentially addictive behaviors defined by the cut-off thresholds of the appropriate scales are presented on the diagonal. Co-occurrences of these behaviors are presented in cells below the diagonal (% of overlap calculated by number of cases with both characteristics divided through all cases, based on valid answers), with the corresponding Phi coefficient values. ∗ Phi correlation is significant at the 0.05 level (2-tailed). ∗∗ Phi correlation is significant at the 0.001 level (2-tailed). Chi-square tests where the level of significance is smaller than the Bonferroni correction level for 21 analysis (P < 0.00243) are marked in bold. Odds Ratios and 95% confidence intervals are presented above the diagonal.
Social networking use was only assessed from the 3rd data collection wave.
Severity of potential behavior addictions by regular psychoactive substance users and non-users
| Problematic Internet Use Questionnaire (PIUQ) | Problematic Online Gaming Questionnaire Short-Form (POGQ-SF) | Bergen Social Media Addiction Scale (BSMAS)a | |||||||
| mean ± SD |
| Cohen's d | mean ± SD |
| Cohen's d | mean ± SD |
| Cohen's d | |
|
| |||||||||
| Self report regular smoker ( |
|
|
| 15.7 ± 6.2 | 0.420 | 0.042 | 9.5 ± 3.6 | 0.617 | 0.039 |
| Self report non-smoker ( |
| 16.0 ± 6.4 | 9.4 ± 3.7 | ||||||
|
| |||||||||
| Drunk 3 or more times in the past 30 days ( |
|
|
|
|
|
|
|
|
|
| Drunk less than 3 times in the past 30 days ( |
|
|
| ||||||
|
| |||||||||
| Past month marijuana users ( | 10.6 ± 3.6 | 0.096 | 0.110 | 16.6 ± 7.0 | 0.031* | 0.136 | 9.8 ± 3.5 | 0.391 | 0.076 |
| Non-users ( | 10.2 ± 3.6 | 15.7 ± 6.2 | 9.6 ± 3.8 | ||||||
Notes. * independent sample t-test is significant at the 0.05 level. t-tests where the level of significance is smaller than the Bonferroni correction level for 21 analysis (P < 0.00243) are marked in bold.
aSocial networking use was only assessed from the third data collection wave. ± = standard deviation.
Severity of potential behavior addictions by regular psychoactive substance users and non-users
| Exercise Addiction Inventory (EAI) | Diagnostic Statistical Manual-IV-Adapted for Juveniles (DSM-IV-MR-J) | The Massachusetts General Hospital Hairpulling Scale (MGH-HPS) | SCOFF Questionnaire eating disorder questionnaire | |||||||||
| mean ± SD |
| Cohen's d | mean ± SD |
| Cohen's d | mean ± SD |
| Cohen's d | mean ± SD |
| Cohen's d | |
|
| ||||||||||||
| Self report regular smoker ( |
|
|
| 0.3 ± 0.8 | 0.015* | 0.123 | 1.3 ± 3.7 | 0.571 | 0.047 |
|
|
|
| Self report non-smoker ( |
| 0.2 ± 0.9 | 1.4 ± 4.0 |
| ||||||||
|
| ||||||||||||
| Drunk 3 or more times in the past 30 days ( | 12.5 ± 5.1 | 0.753 | 0.020 |
|
|
| 1.9 ± 4.7 | 0.083 | 0.133 |
|
|
|
| Drunk less than 3 times in the past 30 days ( | 12.4 ± 5.0 |
| 1.4 ± 3.9 |
| ||||||||
|
| ||||||||||||
| Past month marijuana users ( | 12.2 ± 5.1 | 0.511 | 0.047 |
|
|
| 1.3 ± 4.2 | 0.759 | 0.027 | 0.7 ± 1.0 | 0.505 | 0.043 |
| Non-users ( | 12.5 ± 5.0 |
| 1.4 ± 4.0 | 0.7 ± 1.0 | ||||||||
Notes. * independent sample t-test is significant at the 0.05 level. t-tests where the level of significance is smaller than the Bonferroni correction level for 21 analysis (P < 0.00243) are marked in bold.